How Does Expanded Access Differ from Clinical Trials?
While both pathways provide access to investigational drugs, they serve different purposes. Clinical trials are designed to gather data on the safety and effectiveness of new treatments and are essential for regulatory approval. Expanded access primarily aims to provide treatment options for patients who have no other alternatives and are not eligible for ongoing trials.
